As of close of business last night, Avid Bioservices Inc’s stock clocked out at $7.25, up 6.62% from its previous closing price of $6.80. On the day, 840443 shares were traded.
Ratios:
To gain a deeper understanding of CDMO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.35. In the meantime, Its Debt-to-Equity ratio is 1.07 whereas as Long-Term Debt/Eq ratio is at 1.06.
On March 14, 2023, KeyBanc Capital Markets Upgraded its rating to Overweight which previously was Sector Weight but kept the price unchanged to $20.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 12 ’24 when Kwietniak Matthew R. sold 274 shares for $6.77 per share. The transaction valued at 1,855 led to the insider holds 19,829 shares of the business.
Hart Daniel R sold 2,408 shares of CDMO for $14,857 on Jan 10 ’24. The Chief Financial Officer now owns 79,305 shares after completing the transaction at $6.17 per share. On Jan 10 ’24, another insider, Ziebell Mark R, who serves as the V. P., General Counsel of the company, sold 1,346 shares for $6.17 each. As a result, the insider received 8,305 and left with 63,269 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 3.35 while its Price-to-Book (P/B) ratio in mrq is 2.50.
Stock Price History:
Over the past 52 weeks, CDMO has reached a high of $19.97, while it has fallen to a 52-week low of $4.07.
Shares Statistics:
A total of 62.69M shares are outstanding, with a floating share count of 62.54M. Insiders hold about 1.11% of the company’s shares, while institutions hold 91.01% stake in the company.
Earnings Estimates
As of right now, Avid Bioservices, Inc. analysts gave their recommendation on the stock of the company.
EPS for the following year is $Stocks, with Stocks analysts recommending between $ETF and $Stocks.
